Workflow
百克生物(688276) - 2024 Q3 - 季度财报
BCHTBCHT(SH:688276)2024-10-25 08:06

Financial Performance - The company's revenue for Q3 2024 was CNY 407,611,069.81, a decrease of 40.37% compared to the same period last year[2]. - Net profit attributable to shareholders was CNY 106,765,322.76, down 51.41% year-on-year[2]. - The net profit after deducting non-recurring gains and losses was CNY 109,563,615.52, a decline of 50.06% compared to the previous year[2]. - Total operating revenue for the first three quarters of 2024 was CNY 1,026,012,316.59, a decrease of 17.5% compared to CNY 1,243,193,321.15 in the same period of 2023[16]. - Net profit for the first three quarters of 2024 was CNY 244,369,819.42, a decline of 26.1% from CNY 331,093,189.21 in the same period of 2023[16]. - The net profit for the third quarter of 2024 was CNY 247,493,581.24, down 31.9% from CNY 363,507,360.41 in the third quarter of 2023[25]. - The company reported a total profit of CNY 282,513,112.45 for the third quarter of 2024, down from CNY 405,711,673.11 in the third quarter of 2023, reflecting a decline of approximately 30.4%[25]. Research and Development - R&D investment totaled CNY 30,973,332.82, a decrease of 21.28% year-on-year, while the ratio of R&D investment to revenue increased by 1.84 percentage points to 7.60%[3]. - Research and development expenses for the first three quarters of 2024 amounted to CNY 116,503,270.72, compared to CNY 136,687,474.68 in 2023, indicating a decrease of 14.8%[16]. - Research and development expenses for the first three quarters of 2024 were CNY 116,586,639.97, a decrease of 7.4% compared to CNY 126,006,417.52 in the same period of 2023[24]. Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date was CNY 229,104,857.16, an increase of 91.30% year-on-year[7]. - Cash generated from operating activities was CNY 943,560,340.61 in the first three quarters of 2024, an increase of 22.7% from CNY 768,530,316.02 in 2023[18]. - The net cash flow from operating activities for Q3 2024 was CNY 229,104,857.16, an increase of 91.5% compared to CNY 119,764,590.55 in Q3 2023[19]. - Total operating cash inflows amounted to CNY 1,006,246,535.96, up from CNY 880,133,700.46 in the same period last year[19]. - Cash and cash equivalents at the end of Q3 2024 were CNY 272,254,690.37, down from CNY 454,466,166.62 at the end of Q3 2023[20]. - The company's cash and cash equivalents decreased to RMB 277,889,806.27 from RMB 442,179,928.33, representing a decline of about 37.1%[12]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 5,313,956,757.40, reflecting a 5.31% increase from the end of the previous year[3]. - The company's total assets reached RMB 5,313,956,757.40, an increase from RMB 5,046,237,662.74 at the end of 2023, reflecting a growth of approximately 5.3%[12]. - The company's total liabilities increased to RMB 1,066,780,990.96 from RMB 1,014,865,866.94, indicating a rise of about 5.1%[13]. - Total liabilities as of the end of the third quarter of 2024 were CNY 1,113,880,855.38, up from CNY 1,025,876,086.75 in 2023, representing an increase of 8.6%[16]. - The company's total liabilities rose to CNY 1,110,314,490.49 from CNY 1,021,189,232.11 year-over-year[23]. - The company's non-current assets totaled RMB 3,139,397,099.14, up from RMB 2,801,623,732.76, reflecting an increase of approximately 12.1%[13]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,466[8]. - Total equity attributable to shareholders reached CNY 4,200,075,902.02, an increase of 4.5% from CNY 4,020,361,575.99 in the previous year[16]. - The company's total equity increased to CNY 4,500,775,935.34 from CNY 4,317,937,847.49 year-over-year[23]. Operating Costs and Expenses - Total operating costs for the first three quarters of 2024 were CNY 731,232,689.54, down from CNY 832,335,257.40 in 2023, reflecting a reduction of 12.2%[16]. - The total operating expenses decreased to CNY 777,275,168.81 in the first three quarters of 2024, down from CNY 896,987,699.38 in the same period of 2023[27]. - The company’s sales expenses for the first three quarters of 2024 were CNY 380,401,013.16, down 14.3% from CNY 443,780,118.90 in the same period of 2023[24]. Government Support - The company received government subsidies amounting to CNY 1,321,742.23 during the reporting period[5].